This is a working overview of somatotroph, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-04-04 and is reviewed periodically as new material appears.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 44-residue GHRH analog | Sequence matches human GHRH(1-44); differs only at the N-terminus |
| Nominal molecular mass | Approximately 5,136 Da (free base) | Small variation arises from counterion and salt form |
| Appearance | White to off-white lyophilized powder | Supplied in single-use vials intended for reconstitution |
| Solubility class | Freely soluble in water | Practically insoluble in nonpolar organic solvents |
| Typical storage | 2 to 8 degrees Celsius, protected from light | Reconstituted material is handled according to label instructions |
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
During the 19th century, the Liberal Party was broadly in favour of what would today be called classical liberalism, supporting laissez-faire economic policies such as free trade and minimal government interference in the economy (this doctrine was usually termed Gladstonian liberalism after the Victorian era Liberal Prime Minister William Gladstone). The Liberal Party favoured social reform, personal liberty, reducing the powers of the Crown and the Church of England (many of them were nonconformists) and an extension of the electoral franchise. Sir William Harcourt, a prominent Liberal politician in the Victorian era, said this about liberalism in 1872: If there be any party which is more pledged than another to resist a policy of restrictive legislation, having for its object social coercion, that party is the Liberal party. (Cheers.) But liberty does not consist in making others do what you think right, (Hear, hear.) The difference between a free Government and a Government which is not free is principally this—that a Government which is not free interferes with everything it can, and a free Government interferes with nothing except what it must. A despotic Government tries to make everybody do what it wishes; a Liberal Government tries, as far as the safety of society will permit, to allow everybody to do as he wishes. It has been the tradition of the Liberal party consistently to maintain the doctrine of individual liberty. It is because they have done so that England is the place where people can do more what they please than in any other country in the world.
At 10:20 pm, the tank was at normal pressure, indicating the absence of water. At 10:45 pm, a shift change took place, after which the MIC storage area "would be completely deserted". During this period, a "disgruntled operator entered the storage area and hooked up one of the readily available rubber water hoses to Tank 610, with the intention of contaminating and spoiling the tank's contents." Water began to flow, beginning the chemical reaction that caused the disaster. After midnight, control room operators noticed the pressure rising and realized there was a problem with Tank 610. They discovered the water connection and decided to transfer one ton of the contents out to try to remove the water. The MIC release then occurred. The cover-up activities discovered during the investigation then took place. After over 30 years, in November 2017, S. P. Choudhary, former MIC production manager, claimed in court that the disaster was not an accident but the result of a sabotage that claimed thousands of lives. Choudhary's counsel, Anirban Roy, argued that the theory of design defects was floated by the central government in its endeavour to protect the victims of the tragedy. Everyone else involved in investigating the case "just toed the line of the central government. ... The government and the CBI suppressed the actual truth and saved the real perpetrators of the crime." Roy argued to the district court that M. L. Verma, a disgruntled plant operator at odds with senior management, was behind the sabotage.
Precursor compounds: these compounds are the starting molecules or substrates in a reaction. These may also be viewed as the reactants in a given chemical process. Chemical energy: chemical energy can be found in the form of high energy molecules. These molecules are required for energetically unfavourable reactions. Furthermore, the hydrolysis of these compounds drives a reaction forward. High energy molecules, such as ATP, have three phosphates. Often, the terminal phosphate is split off during hydrolysis and transferred to another molecule. Catalysts: these may be for example metal ions or coenzymes and they catalyze a reaction by increasing the rate of the reaction and lowering the activation energy. In the simplest sense, the reactions that occur in biosynthesis have the following format:
The third mountain-building event was the Acadian orogeny which occurred between 375 and 359 million years ago. The Acadian orogeny was caused by a series of collisions of pieces of crust from the Avalonia Terrane, sections broken off from continent of Gondwana, with the North American Plate. The collision initiating this orogeny resulted in the closing of the southern Iapetus Ocean and the formation of a high mountain belt. After the Acadian collision took place, Gondwana began to retreat from Laurentia with the newly accreted Avalonian terranes left behind. As Gondwana moved away, a new ocean opened up, the Rheic Ocean, during the Middle to Late Devonian, and subsequently its closure would result in the formation of the Alleghanian orogeny.
"Mummy" . Encyclopædia Britannica. Vol. 18 (11th ed.). 1911. Mummies at HowStuffWorks Comparison Between Egyptian and Incan Mummies at the Wayback Machine (archived 24 March 2022) U.S. Museum to Return Ramses I Mummy to Egypt (30 April 2003) – National Geographic "Modern Mummification". Summum. Retrieved 29 May 2006. Simon Cleveland, About the Unknown Mummy E at the Wayback Machine (archived 27 October 2009) Mummies Around the World – Dried, Smoked, or Thrown in a Bog (18 January 2016) – National Geographic Interview with Prof. Ann Rosalie David on Egyptian mummies, "History of Egypt Podcast" series by Eyptologist Dominic Perry (2020) The Virtual Mummy: Unwrapping a Mummy by Mouse Click
Sources: en.wikipedia.org
== Prevention == Prevention of metabolic syndrome centres on improving modifiable lifestyle factors that contribute to excess visceral fat, insulin resistance, and cardiometabolic risk. Even modest, sustained changes in activity and diet have been shown to improve multiple components of the syndrome. Regular physical activity is strongly supported by clinical and public-health organizations. Guidelines from the American Heart Association recommend at least 150 minutes per week of moderate-intensity aerobic activity, or 75 minutes of vigorous activity, with additional muscle-strengthening exercises on two or more days per week. Walking—even in shorter bouts that accumulate to 30 minutes per day—is associated with measurable improvements in blood pressure, insulin sensitivity, and waist circumference. Dietary patterns emphasizing whole foods appear beneficial. Evidence from observational studies and randomized trials supports Mediterranean-style eating, which is associated with reduced central adiposity and improved lipid and glycaemic measures. Calorie reduction, improved diet quality, and lowering intake of refined carbohydrates also contribute to improved metabolic parameters. Time-restricted eating (a form of intermittent fasting) has shown preliminary benefits in reducing waist circumference and fasting glucose in adults with metabolic syndrome, though long-term effects remain under investigation. Other behavioural factors influence prevention outcomes.
=== Nervous system === Progesterone, like pregnenolone and dehydroepiandrosterone (DHEA), belongs to an important group of endogenous steroids called neurosteroids. The steroid can be metabolized within all parts of the central nervous system. Neurosteroids are neuromodulators and are neuroprotective, neurogenic, and regulate neurotransmission and myelination. The effects of progesterone as a neurosteroid are mediated predominantly through its interactions with non-nuclear PRs, namely the mPRs and PGRMC1, as well as certain other receptors, such as the σ1 and nACh receptors.
Surface tension theory – according to this theory, emulsification takes place by reduction of interfacial tension between two phases Repulsion theory – According to this theory, the emulsifier creates a film over one phase that forms globules, which repel each other. This repulsive force causes them to remain suspended in the dispersion medium Viscosity modification – emulgents like acacia and tragacanth, which are hydrocolloids, as well as PEG (polyethylene glycol), glycerine, and other polymers like CMC (carboxymethyl cellulose), all increase the viscosity of the medium, which helps create and maintain the suspension of globules of dispersed phase
== Synthesis == The glycosylation of proteins has an array of different applications from influencing cell to cell communication to changing the thermal stability and the folding of proteins. Due to the unique abilities of glycoproteins, they can be used in many therapies. By understanding glycoproteins and their synthesis, they can be made to treat cancer, Crohn's Disease, high cholesterol, and more. The process of glycosylation (binding a carbohydrate to a protein) is a post-translational modification, meaning it happens after the production of the protein. Glycosylation is a process that roughly half of all human proteins undergo and heavily influences the properties and functions of the protein. Within the cell, glycosylation occurs in the endoplasmic reticulum.
Sources: en.wikipedia.org
==== Agitation of hydrophilic primer or adhesive during application ==== Besides having adequate dentinal moisture, agitation of the primers during application of two-step etch-and-rinse adhesives may be critical for optimal penetration into the demineralized collagen fibres. It also may aid the evaporation of residual water in the adhesive and hybrid layers, thus preventing nano leakage. In a clinical trial comparing the performance of Prime & Bond NT using no rubbing action, slight rubbing action and vigorous rubbing action in the restoration of NCCLs, 92.5% of restorations in vigorous rubbing action group were found to retain after 24 months of clinical service. For the other two groups, the retention rates of the restoration were slightly lower, at 82.5%.
== Overview == General Blood was founded by David Mitchell and Ben Bowman, who both received MBA’s from the Carlson School of Management at the University of Minnesota. Bowman began researching the blood distribution industry in 2007 while still enrolled in the MBA program. General Blood LLC was created in 2010 and is headquartered in downtown Minneapolis, Minnesota on the Mississippi River. Ben Bowman is chief executive officer at General Blood, and David Mitchell is the executive vice president. In 2013, General Blood was an exhibitor for the Clinical Laboratory Management Association. In 2012, General Blood was a Minnesota Cup Semi-Finalist in the Bio-Science and Health IT Division.
A third Reform UK councillor on Cornwall Council resigns making the Liberal Democrats the single largest party. 25 October – Lucy Powell wins the 2025 Labour Party deputy leadership election. 26 October – Former Bank of England governor Mervyn King criticises a potential mansion tax. 27 October – A report from the Home Affairs Select Committee claims that the Home Office has "squandered" billions of pounds of taxpayers' money on asylum accommodation. Two Reform UK councillors on Kent County Council are expelled from the party for "bringing it into disrepute". 28 October – Steve Reed, Secretary of State for Housing, Communities and Local Government, announces that Surrey County Council will be abolished and replaced by two unitary authorities; East Surrey and West Surrey. Stormont appoints Pól Deeds and Lee Reynolds as Northern Ireland's first Irish language and Ulster-Scots commissioners respectively. 29 October – Chancellor Rachel Reeves refers herself to the Parliamentary Commissioner for Standards after saying that she broke housing rules by unlawfully renting out her family home without a licence. The Electoral Management Board for Scotland announces that votes for the 2026 Scottish Parliament election will be counted the day after the election rather than overnight. 30 October – Plaid Cymru leader Rhun ap Iorwerth and SNP leader John Swinney hold talks to develop a "progressive alliance" between the two parties. 31 October – Prince Andrew is formally stripped of his prince title and will henceforth be known as Andrew Mountbatten-Windsor.
Sources: en.wikipedia.org
It is a synthetic peptide built from 44 amino acids arranged in the same order as human growth hormone-releasing hormone. A short fatty-acid chain, described as a trans-3-hexenoyl group, is attached to the first amino acid. The finished molecule is formulated as a sterile powder that is dissolved before use.
No. It is a releasing-factor analog that signals the pituitary gland to secrete growth hormone, whereas recombinant growth hormone is the hormone itself administered directly. The two are chemically distinct and act at different points in the same endocrine pathway. This distinction is often lost in informal discussion.
Native growth hormone-releasing hormone is broken down within minutes by dipeptidyl peptidase-4 in the bloodstream. Adding the hexenoyl group at the N-terminus shields the peptide from that enzyme. The modification does not change the receptor it targets, only how long the peptide survives in circulation.
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.